Patient Education Strategy for Breast Cancer Patients During Perioperative Hospitalization Stage

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorFudan University

About this trial

Introduction Breast cancer remains a leading global health concern, with significant psychological challenges during the perioperative period. Traditional patient education focuses on disease management but often neglects emotional and cognitive needs. Perioperative inpatients are relatively stable and have the time and mental space for deeper education and psychological support. This study evaluates the clinical significance of a medical humanities-based education strategy for breast cancer patients during hospitalization, aiming to enhance psychological resilience, treatment adherence, and quality of life.

Methods and Analysis This prospective, non-randomized, open-label study will include female patients with early-stage breast cancer scheduled for surgery at Fudan University Shanghai Cancer Center. Participants will be allocated to two cohorts: practical education group and mental enhanced group. The primary endpoint is psychological assessment at hospital discharge, including anxiety (GAD-7), depression (PHQ-9), and sleep quality (ISI). Secondary endpoints include the proportion of patients opting for breast-conserving procedures, incidence of postoperative complications, long-term treatment adherence (MMAS-8), patients' disease-coping resilience (CD-RISC-10), and quality of life assessment (EORTC QLQ instruments) at 12-month follow-up. Data collection and statistical analysis will be conducted using validated instruments and software, with significance set at p ≤0.05.

Ethics and Dissemination Approved by the FUSCC ethics committee, all participants provide informed consent. Results will be disseminated through international conferences and peer-reviewed journals. The study adheres to ethical guidelines, ensuring data confidentiality via encrypted platforms. Authors declare no conflicts of interest, supported by Shanghai Municipal Science and Technology Innovation Action Plan (24DZ2303500). Findings aim to optimize perioperative education strategies, addressing psychological and informational needs of breast cancer patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

More than 18 years old

Female

Patient with early-stage breast cancer with preoperative pathology confirming invasive breast carcinoma or ductal carcinoma in situ

No clinical or imaging evidence of distant metastasis

Disqualifiers

Patients with locally advanced breast cancer to receive neoadjuvant therapy

Patients currently participating in other clinical trials, which may have impact on the participation in this trial

Previous history of breast cancer (patients with ipsilateral recurrence after breast sparing surgery)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Medical Humanities-based Patient Education Strategy

    Other intervention

    Medical Humanities-based Patient Education with Comic-based Medical Education Materials for Breast Cancer Patients during Perioperative Hospitalization Stage

Treatment groups

1,138 Participants
are divided into 2 treatment groups
Group A: Medical Humanities-based Patient Education StrategyActive comparator 1 intervention
Group B: Routine Patient Education StrategyNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

anxiety status at hospital discharge

anxiety status at hospital discharge evaluated using the GAD-7 questionnaire Generalized Anxiety Disorder scale, GAD-7 (0-21 points): Cut-off values of 5, 10, and 15 delineated mild, moderate, and severe anxiety

Time frame
Five days after surgery
2

depression severity at hospital discharge

depression severity at hospital discharge assessed with the PHQ-9 instrument Patient Health Questionnaire, PHQ-9 (0-27 points): Thresholds at 5, 10, 15, and 20 classified mild, moderate, moderately severe, and severe depression.

Time frame
Five days after surgery
3

sleep quality at hospital discharge

sleep quality at hospital discharge measured via the ISI scale Insomnia Severity Index, ISI (0-28 points): Scores ≥8, ≥15, and ≥22 indicated subthreshold, moderate, and severe insomnia.

Time frame
Five days after surgery

Secondary outcomes

1

The proportion of patients opting for breast-conserving cosmetic procedures

including breast-conserving surgery, oncoplastic breast-conserving surgery, implant-based or autologous breast reconstruction

Time frame
Five days after surgery
2

Incidence of postoperative complications requiring surgical intervention

Incidence of postoperative complications requiring surgical intervention within 12 months after surgery

Time frame
12 months follow-up
3

Long-term treatment adherence

Long-term treatment adherence evaluation at the 12-month postoperative follow-up (assessed using the MMAS-8 scale) 8-item Morisky Medication Adherence Scale, MMAS-8 (0-8 points): Medication adherence was categorized as optimal (≥6) or suboptimal.

Time frame
12 months follow-up
4

Patients' disease-coping resilience

Patients' disease-coping resilience at 12 months postoperatively (evaluated with the CD-RISC-10 instrument) (10-item Connor-Davidson Resilience Scale, CD-RISC-10 (0-40 points): Psychological resilience was dichotomized using the 29.5 threshold (high vs. low resilience).

Time frame
12 months follow-up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: